TipRanks
Blau Farmaceutica SA (BR:BLAU3)
:BLAU3
Brazil Market
BLAU3
Blau Farmaceutica SA
RESEARCH TOOLSreports

Blau Farmaceutica SA (BLAU3) Ratios

― Followers

Blau Farmaceutica SA Ratios

BR:BLAU3's free cash flow for Q2 2026 was R$0.42. For the 2026 fiscal year, BR:BLAU3's free cash flow was decreased by R$ and operating cash flow was R$0.23. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.23 2.47 3.12 4.63 4.52
Quick Ratio
 2.25 1.57 1.99 2.75 2.99
Cash Ratio
 0.07 0.06 0.06 0.09 0.04
Solvency Ratio
 0.18 0.26 0.21 0.27 0.57
Operating Cash Flow Ratio
 0.58 0.29 0.94 0.66 0.46
Short-Term Operating Cash Flow Coverage
 1.62 0.80 7.57 3.14 2.15
Net Current Asset Value
R$ 442.88MR$ 517.95MR$ 415.09MR$ 495.59MR$ 996.75M
Leverage Ratios
Debt-to-Assets Ratio
 0.21 0.16 0.16 0.20 0.12
Debt-to-Equity Ratio
 0.37 0.26 0.26 0.30 0.17
Debt-to-Capital Ratio
 0.27 0.21 0.21 0.23 0.15
Long-Term Debt-to-Capital Ratio
 0.20 0.11 0.17 0.20 0.10
Financial Leverage Ratio
 1.73 1.60 1.58 1.53 1.37
Debt Service Coverage Ratio
 1.41 0.86 2.53 2.95 3.58
Interest Coverage Ratio
 3.96 4.40 5.47 5.63 12.43
Debt to Market Cap
 0.34 0.17 0.29 0.28 0.08
Interest Debt Per Share
 4.11 2.25 3.50 3.64 1.94
Net Debt to EBITDA
 1.54 1.40 1.29 1.42 0.57
Profitability Margins
Gross Profit Margin
39.76%38.33%37.55%35.72%47.47%
EBIT Margin
25.11%19.37%20.20%26.69%35.61%
EBITDA Margin
29.28%23.15%23.15%29.52%37.19%
Operating Profit Margin
19.15%19.37%19.48%15.41%31.98%
Pretax Profit Margin
16.81%22.82%16.64%24.35%33.30%
Net Profit Margin
13.09%17.33%12.38%18.20%25.83%
Continuous Operations Profit Margin
13.14%17.43%12.17%18.03%25.62%
Net Income Per EBT
77.90%75.93%74.41%74.74%77.55%
EBT Per EBIT
87.77%117.81%85.40%158.00%104.14%
Return on Assets (ROA)
5.81%8.11%6.37%8.18%14.54%
Return on Equity (ROE)
10.11%12.98%10.04%12.48%19.94%
Return on Capital Employed (ROCE)
10.18%11.50%11.89%7.78%21.14%
Return on Invested Capital (ROIC)
7.42%7.99%8.48%5.61%15.65%
Return on Tangible Assets
7.05%9.77%7.43%8.68%15.53%
Earnings Yield
9.72%9.09%12.32%12.42%10.75%
Efficiency Ratios
Receivables Turnover
 3.47 2.90 3.68 3.03 3.34
Payables Turnover
 4.19 3.94 3.83 4.92 4.52
Inventory Turnover
 1.66 1.51 1.81 1.40 1.30
Fixed Asset Turnover
 1.77 1.68 2.08 1.86 2.59
Asset Turnover
 0.44 0.47 0.51 0.45 0.56
Working Capital Turnover Ratio
 1.36 1.50 1.49 1.09 1.06
Cash Conversion Cycle
 238.25 274.79 205.86 306.50 309.34
Days of Sales Outstanding
 105.31 126.07 99.19 120.61 109.12
Days of Inventory Outstanding
 220.06 241.32 201.95 260.04 281.03
Days of Payables Outstanding
 87.11 92.61 95.28 74.15 80.82
Operating Cycle
 325.36 367.40 301.14 380.65 390.16
Cash Flow Ratios
Operating Cash Flow Per Share
 1.68 0.74 2.85 1.24 0.96
Free Cash Flow Per Share
 0.57 -0.13 2.06 0.59 -0.05
CapEx Per Share
 1.12 0.87 0.79 0.65 0.80
Free Cash Flow to Operating Cash Flow
 0.34 -0.18 0.72 0.48 -0.05
Dividend Paid and CapEx Coverage Ratio
 1.15 0.65 2.57 1.22 0.62
Capital Expenditure Coverage Ratio
 1.51 0.85 3.59 1.92 1.20
Operating Cash Flow Coverage Ratio
 0.45 0.37 0.91 0.36 0.55
Operating Cash Flow to Sales Ratio
 0.22 0.13 0.29 0.16 0.12
Free Cash Flow Yield
5.34%-1.23%20.77%5.25%-0.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 9.48 11.03 8.13 8.05 9.31
Price-to-Sales (P/S) Ratio
 1.36 1.91 1.00 1.47 2.40
Price-to-Book (P/B) Ratio
 1.03 1.43 0.81 1.00 1.86
Price-to-Free Cash Flow (P/FCF) Ratio
 18.73 -81.56 4.82 19.05 -410.78
Price-to-Operating Cash Flow Ratio
 6.24 14.61 3.48 9.12 19.67
Price-to-Earnings Growth (PEG) Ratio
 -0.31 -0.56 -0.60 -0.27 0.80
Price-to-Fair Value
 1.03 1.43 0.81 1.00 1.86
Enterprise Value Multiple
 6.19 9.64 5.63 6.39 7.03
Enterprise Value
 3.24B 3.80B 2.29B 2.59B 3.68B
EV to EBITDA
 6.19 9.64 5.63 6.39 7.03
EV to Sales
 1.81 2.23 1.30 1.89 2.62
EV to Free Cash Flow
 24.95 -95.47 6.25 24.51 -446.94
EV to Operating Cash Flow
 8.40 17.10 4.51 11.74 21.40
Tangible Book Value Per Share
 7.03 5.46 9.36 10.24 9.24
Shareholders’ Equity Per Share
 10.20 7.57 12.18 11.26 10.16
Tax and Other Ratios
Effective Tax Rate
 0.22 0.24 0.27 0.26 0.23
Revenue Per Share
 7.81 5.67 9.87 7.73 7.84
Net Income Per Share
 1.02 0.98 1.22 1.41 2.03
Tax Burden
 0.78 0.76 0.74 0.75 0.78
Interest Burden
 0.67 1.18 0.82 0.91 0.94
Research & Development to Revenue
 0.02 0.02 0.02 0.03 0.03
SG&A to Revenue
 0.20 0.18 0.16 0.10 0.08
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.44 0.75 1.74 0.88 0.37
Currency in BRL